US2015125920A1PendingUtilityA1

Enhanced pyruvate to acetolactate conversion in yeast

Assignee: BUTAMAX ADVANCED BIOFUELS LLCPriority: Jun 5, 2008Filed: Dec 16, 2014Published: May 7, 2015
Est. expiryJun 5, 2028(~1.9 yrs left)· nominal 20-yr term from priority
C12P 7/16C12N 15/81C12P 7/04C12N 15/09C12N 9/10C12N 9/88C12Y 202/01006Y02E50/10Y02P20/52
69
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A high flux in conversion of pyruvate to acetolactate was achieved in yeast through expression of acetolactate synthase in the cytosol in conjunction with reduction in pyruvate decarboxylase activity. Additional manipulations to improve flux to acetolactate are reduced pyruvate dehydrogenase activity and reduced glycerol-3-phosphate dehydrogenase activity. Production of compounds having acetolactate as an upstream intermediate benefit from the increased conversion of pruvate to acetolactate in the described strains.

Claims

exact text as granted — not AI-modified
What is claimed: 
     
         1 - 22 . (canceled) 
     
     
         23 . A recombinant yeast microorganism for producing isobutanol, the recombinant yeast microorganism comprising an engineered isobutanol biosynthetic pathway, wherein said engineered isobutanol biosynthetic pathway comprises the following substrate to product conversions:
 (a) pyruvate to acetolactate;   (b) acetolactate to 2,3-dihydroxyisovalerate;   (c) 2,3-dihydroxyisovalerate to a-ketoisovalerate;   (d) α-ketoisovalerate to valine;   (e) valine to isobutylamine; and   (f) isobutylamine to isobutyraldehyde;   
       wherein
 i) the substrate to product conversion of step (a) is performed by an acetolactate synthase enzyme; 
 ii) the substrate to product conversion of step (b) is performed by an acetohydroxy acid isomeroreductase enzyme; 
 iii) the substrate to product conversion of step (c) is performed by an acetohydroxy acid dehydratase enzyme; 
 iv) the substrate to product conversion of step (d) is performed by a transaminase; 
 v) the substrate to product conversion step of (e) is performed by a valine decarboxylase; and 
 vi) the substrate to product conversion step of (f) is performed by an omega transaminase; 
 
       and wherein the recombinant yeast microorganism is substantially free of at least one enzyme having pyruvate decarboxylase activity and is substantially free of at least one enzyme having glycerol-3-phosphate dehydrogenase activity. 
     
     
         24 . The recombinant yeast of  claim 23 , wherein the engineered isobutanol biosynthetic pathway further comprises the following pathway step:
 (g) isobutyraldehyde to isobutanol   
       wherein the substrate to product conversion of step (g) is performed by an alcohol dehydrogenase enzyme. 
     
     
         25 . The recombinant yeast of  claim 23 , wherein the conversion of pyruvate to acetolactate is catalyzed by a cytosol-localized polypeptide having acetolactate synthase activity. 
     
     
         26 . The recombinant yeast of  claim 25 , wherein the polypeptide having acetolactate synthase activity has a substrate preference for pyruvate over ketobutyrate. 
     
     
         27 . The recombinant yeast of  claim 25 , wherein the polypeptide having acetolactate synthase activity is a  Lactococcus lactis  acetolactate synthase. 
     
     
         28 . The recombinant yeast of  claim 25 , wherein the polypeptide having acetolactate synthase activity is a  Bacillus subtilis  acetolactate synthase. 
     
     
         29 . The recombinant yeast of  claim 23 , wherein the yeast cell comprises a disruption in at least one gene encoding a polypeptide having pyruvate decarboxylase activity or controlling pyruvate decarboxylase gene expression. 
     
     
         30 . The recombinant yeast of  claim 29 , wherein the polypeptide is selected from the group consisting of PDC1, PDC2, PDC5, and PDC6. 
     
     
         31 . The recombinant yeast of  claim 30  comprising a disruption in PDC1 and PDC5. 
     
     
         32 . The recombinant yeast of  claim 23  comprising a disruption in at least one gene encoding an NAD-dependent glycerol-3-phosphate dehydrogenase selected from the group consisting of GPD1 and GPD2. 
     
     
         33 . The recombinant yeast of  claim 23 , wherein the conversion of pyruvate to acetolactate is at least about 60% of theoretical yield. 
     
     
         34 . The recombinant yeast of  claim 23 , further comprising a balance in reducing equivalents, wherein the conversion of pyruvate to acetolactate is at least about 86% of theoretical yield. 
     
     
         35 . The recombinant yeast of  claim 23 , wherein the yeast further comprises a construct for heterologous expression of a secondary alcohol dehydrogenase. 
     
     
         36 . The recombinant yeast of  claim 23 , wherein the yeast is Kluyveromyces lactis. 
     
     
         37 . The recombinant yeast of  claim 23 , wherein the yeast is Saccharomyces cerevisiae. 
     
     
         38 . A method of producing isobutanol, comprising;
 (a) providing the recombinant yeast microorganism according to  claim 23 ; and   (b) growing the recombinant yeast microorganism under conditions where isobutanol is produced.   
     
     
         39 . The method of  claim 38  further comprising (c) recovering the isobutanol.

Join the waitlist — get patent alerts

Track US2015125920A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.